Jan 8, 2026 02:48AM
Nov 19, 2025 04:42AM
Oct 1, 2024 02:02AM
Sep 24, 2024 02:06AM
Apr 17, 2024 03:09AM
Feb 13, 2024 01:30AM
Dec 7, 2023 01:35AM Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea
Nov 24, 2023 03:35AM
Aug 4, 2023 02:37AM
May 13, 2022 02:30AM
Sep 7, 2021 04:00AM
Aug 12, 2021 03:00AM
Feb 16, 2021 07:30AM
Feb 12, 2021 03:00AM Sosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2020
Nov 11, 2020 02:55AM
Sep 3, 2020 04:57AM
Aug 13, 2020 03:52AM
Jul 16, 2020 02:47AM
Dec 12, 2018 01:42AM
Oct 17, 2018 07:55PM
May 2, 2017 09:41PM Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics
Nov 29, 2016 08:53PM
Nov 29, 2016 07:15PM
Apr 28, 2016 05:05AM
Apr 7, 2016 06:32AM
Apr 7, 2016 01:34AM
Apr 6, 2016 07:30PM
Nov 25, 2015 03:00AM Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine
Aug 6, 2015 02:05AM
Aug 6, 2015 02:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All